Iteos Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Iteos Therapeutics shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Iteos Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Iteos Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Iteos Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $4.3M | 429k | 9.97 |
| 2024-12-31 | $1.9M | 251k | 7.68 |
| 2024-09-30 | $5.1M | 501k | 10.21 |
| 2024-06-30 | $16M | 1.1M | 14.84 |
| 2024-03-31 | $22M | 1.6M | 13.64 |
| 2023-12-31 | $12M | 1.1M | 10.95 |
| 2023-09-30 | $2.9M | 262k | 10.95 |
| 2023-06-30 | $2.3M | 177k | 13.25 |
| 2022-12-31 | $17M | 847k | 19.53 |
| 2022-06-30 | $28M | 1.1M | 26.32 |
| 2022-03-31 | $26M | 802k | 32.18 |
| 2021-06-30 | $0 | 91k | 0.00 |
| 2020-12-31 | $286k | 8.5k | 33.78 |
| 2020-09-30 | $59k | 2.4k | 24.84 |
Top funds holding Iteos Therapeutics
View all funds holding Iteos Therapeutics